About Fusion Genomics

FUSION GENOMICS is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing.

Our ONETest products, in combination with our FUSIONCloud™ data analysis platform, enable rapid identification of the genetic signatures of human pathogens and cancers accurately and economically.

FUSION’s ONETest platform is currently being tested at various key opinion leaders in Canada and the European Union.

Investors interested in discussing backing for FUSION GENOMICS, please Contact us.